Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study.
De Souza MC, Walker AF, Robinson PA, Bolland K. De Souza MC, et al. Among authors: bolland k. J Womens Health Gend Based Med. 2000 Mar;9(2):131-9. doi: 10.1089/152460900318623. J Womens Health Gend Based Med. 2000. PMID: 10746516 Clinical Trial.
Unexpected benefit of sorbitol placebo in Mg intervention study of premenstrual symptoms: implications for choice of placebo in RCTs.
Walker AF, De Souza MC, Marakis G, Robinson PA, Morris AP, Bolland KM. Walker AF, et al. Among authors: bolland km. Med Hypotheses. 2002 Mar;58(3):213-20. doi: 10.1054/mehy.2001.1407. Med Hypotheses. 2002. PMID: 12018972 Clinical Trial.
Evaluation of a sequential global test of improved recovery following stroke as applied to the ICTUS trial of citicoline.
Bolland K, Whitehead J, Cobo E, Secades JJ. Bolland K, et al. Pharm Stat. 2009 Apr-Jun;8(2):136-49. doi: 10.1002/pst.344. Pharm Stat. 2009. PMID: 18637642
Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methods.
Whitehead A, Sooriyarachchi MR, Whitehead J, Bolland K. Whitehead A, et al. Among authors: bolland k. Stat Med. 2008 May 10;27(10):1646-66. doi: 10.1002/sim.3046. Stat Med. 2008. PMID: 17886243
Sample size review in a head injury trial with ordered categorical responses.
Bolland K, Sooriyarachchi MR, Whitehead J. Bolland K, et al. Stat Med. 1998 Dec 30;17(24):2835-47. doi: 10.1002/(sici)1097-0258(19981230)17:24<2835::aid-sim933>;2-8. Stat Med. 1998. PMID: 9921605
A safety monitoring procedure for a clinical drug development program, with application to the assessment of a novel COX-2 inhibitor.
Bolland K, Whitehead J, Oldham M. Bolland K, et al. J Biopharm Stat. 2008;18(4):737-49. doi: 10.1080/10543400802071410. J Biopharm Stat. 2008. PMID: 18607805
How a sequential design would have affected the GAIN International Study of gavestinel in stroke.
Bolland K, Weeks A, Whitehead J, Lees KR; GAIN Interanational Steering Committee and the Investigators. Bolland K, et al. Cerebrovasc Dis. 2004;17(2-3):111-7. doi: 10.1159/000075778. Epub 2003 Dec 23. Cerebrovasc Dis. 2004. PMID: 14707409
Formal approaches to safety monitoring of clinical trials in life-threatening conditions.
Bolland K, Whitehead J. Bolland K, et al. Stat Med. 2000 Nov 15;19(21):2899-917. doi: 10.1002/1097-0258(20001115)19:21<2899::aid-sim597>;2-o. Stat Med. 2000. PMID: 11042622
Mid-trial design reviews for sequential clinical trials.
Whitehead J, Whitehead A, Todd S, Bolland K, Sooriyarachchi MR. Whitehead J, et al. Among authors: bolland k. Stat Med. 2001 Jan 30;20(2):165-76. doi: 10.1002/1097-0258(20010130)20:2<165::aid-sim649>;2-a. Stat Med. 2001. PMID: 11169595
Using historical lesion volume data in the design of a new phase II clinical trial in acute stroke.
Whitehead J, Bolland K, Valdès-Márquez E, Lihic A, Ali M, Lees K; Virtual International Stroke Trials Archive Collaborators. Whitehead J, et al. Among authors: bolland k. Stroke. 2009 Apr;40(4):1347-52. doi: 10.1161/STROKEAHA.108.531442. Epub 2009 Feb 19. Stroke. 2009. PMID: 19228847
17 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page